According to the company, the sales of these products would strengthen their product offering and is hopeful to be a solid contributor to both sales and profits in fiscal 2012.
Lannett president and CEO Arthur P Bedrosian said the sales of the three items were in their guidance issued during the earnings call.
The company is known for developing, manufacturing, packaging, marketing and distribution of generic pharmaceutical products.